2025-10-11 - Analysis Report
Okay, let's analyze Procter & Gamble (PG) based on the provided data. Here's the report:

## Procter & Gamble (PG) Analysis

Procter & Gamble Co. is a multinational consumer goods corporation that provides branded products worldwide.

### 1. Performance vs. S&P 500 (VOO)

*   **PG Cumulative Return:** 30.13%
*   **VOO Cumulative Return:** 99.08%
*   **Spread (PG - VOO):** -68.5%
*   **Historical Spread Range:** Max: 24.9, Min: -68.5
*   **Relative Spread Position:** 0.0 (Currently at the lowest end of its historical range compared to VOO)

**Analysis:** PG has significantly underperformed the S&P 500 (VOO) over the period covered by the cumulative return data. The current spread is at the lowest end of its historical range, indicating substantial relative underperformance.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 21.0%   | 7.9%    | -8.0%   | 0.0   | 215.1  |
| 2016-2018  | 9.0%    | 67.3%   | -6.0%   | 0.1   | 215.2  |
| 2017-2019  | 24.0%   | 70.4%   | 2.0%    | 0.3   | 292.4  |
| 2018-2020  | 27.0%   | 78.8%   | 4.0%    | 0.4   | 325.8  |
| 2019-2021  | 41.0%   | 78.8%   | -5.0%   | 0.5   | 383.0  |
| 2020-2022  | 13.0%   | 79.4%   | 13.0%   | 0.6   | 354.9  |
| 2021-2023  | 26.0%   | 79.4%   | 24.0%   | 0.4   | 343.1  |
| 2022-2024  | 9.0%    | 79.4%   | -12.0%  | 0.4   | 392.5  |
| 2023-2025  | -14.0%  | 80.1%   | -77.0%  | 0.2   | 350.1  |

**Analysis of Alpha/Beta Table:**

*   **Alpha:** PG's alpha has fluctuated significantly over different periods. Recent periods (2022-2025) show significantly negative Alpha, indicating underperformance relative to its benchmark after accounting for risk.
*   **Beta:** PG's beta is generally low (between 0.0 and 0.6), indicating lower volatility than the market (S&P 500).  A beta of less than 1 suggests PG is less sensitive to market movements.
*   **CAGR:** Compound Annual Growth Rate varied, with the most recent period (2023-2025) showing a negative return.
*   **MDD:** The Maximum Drawdown figures are high, particularly in recent years, indicating significant potential losses from peak to trough.
*   **Cap(B):** PG's market capitalization has fluctuated over the years, providing a sense of the company's size and scale during these periods.

### 2. Recent Stock Price Trends

*   **Current Price:** 149.54
*   **Last Market Price:** 149.58
*   **Previous Close:** 150.58
*   **Change:** -0.66
*   **5-day Moving Average:** 151.09
*   **20-day Moving Average:** 153.8653
*   **60-day Moving Average:** 155.355

**Analysis:** The stock is currently trading below all its moving averages (5, 20, and 60 days), suggesting a short-term downtrend. The negative change from the previous close confirms this recent downward pressure.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 27.95 (Oversold)
*   **PPO:** -0.2386
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Delta_Previous_Relative_Divergence:** -0.1 (Short-term decrease)
*   **Expected Return (%):** 289.6 (Long-term, relative to S&P 500)
*   **Price Change:** price': 149.58, 'previousClose': 150.58, 'change': -0.66

**Analysis:**

*   The **MRI** indicates a high investment recommendation, suggesting the model views PG as relatively safe.
*   The **RSI** is in oversold territory (below 30), which *could* indicate a potential buying opportunity (but should not be considered in isolation).
*   The **PPO** (Percentage Price Oscillator) is negative, suggesting a downtrend.
*   The recent negative price change confirms the short-term downward momentum.
*   The "Hybrid Signal" leans toward buying, suggesting confidence in the stock's safety, in spite of the indicators.
*   The "Delta_Previous_Relative_Divergence" confirms short-term downward pressure.
*   The extremely high "Expected Return" should be viewed with caution; it represents a model's projection of long-term outperformance relative to the S&P 500.

### 4. Recent News & Significant Events

*   **Mixed Headlines:** The news articles present a mixed picture.
    *   Some articles highlight financial strength but recent weakness.
    *   JPMorgan and UBS adjusted price targets, with JPMorgan lowering theirs while UBS maintains a "Buy" rating (but also lowers its target).
    *   New product launches (Zevo) can be seen as positive.
    *   Earnings expectations are being discussed.

**Impact:** The news suggests caution. Analyst target adjustments indicate some uncertainty, while new product launches offer potential for growth.

**4-2. Analyst Opinions:**

*   **Consensus:** "Buy" (Mean: 2.04 on a 1-5 scale)
*   **Opinions:** 22 analysts
*   **Target Price (avg/high/low):** 169.32 / 186.00 / 147.00
*   **Recent Rating Changes:** Not available

**Analysis:** The overall analyst consensus leans towards a "Buy" rating, with an average target price significantly above the current price. However, the range of target prices is wide, suggesting varying degrees of confidence.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출          |
|------------|-------|---------------|
| 2025-04-24 | 1.58  | 19.78 B$      |
| 2025-01-22 | 1.94  | 21.88 B$      |
| 2024-10-18 | 1.65  | 21.74 B$      |
| 2024-04-19 | 1.56  | 20.20 B$      |
| 2025-04-24 | 1.56  | 20.20 B$      |

**Analysis:** The latest earnings data shows fluctuating EPS and revenue figures. There appears to be a typo with duplicate entry. Need to clarify.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $20.89B    | 49.11%        |
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |
| 2024-06-30   | $20.53B    | 49.60%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-06-30   | $52.01B    | 6.95%  |
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |
| 2024-06-30   | $50.29B    | 6.24%  |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable over the past five quarters.
*   **Profit Margin:** Profit margins have fluctuated, remaining in the high 40% to low 50% range.
*   **Equity:** Equity has shown a gradual increase over the period.
*   **ROE:** Return on Equity (ROE) has varied, with the highest ROE observed in Q4 2024.

### 7. Overall Assessment

PG presents a mixed picture:

*   **Underperformance:** Significant underperformance relative to the S&P 500.
*   **Downtrend:** Recent stock price trends indicate a short-term downtrend.
*   **Oversold:** The RSI suggests the stock may be oversold, but this should be considered alongside other indicators.
*   **Analyst Sentiment:** Analyst consensus leans towards "Buy," but target price adjustments suggest some uncertainty.
*   **Financials:** Revenue, profit margins, equity, and ROE have shown stability or gradual growth.
*   **High Investment Recommended:** MRI suggest stock is relatively safe.
*   **News:** News headlines are mixed.

**Conclusion:**

While PG's financial stability and analyst sentiment are encouraging, the underperformance relative to the market, recent price decline, and negative news headlines suggest caution. The high "Expected Return" should be viewed skeptically. Investors should conduct further due diligence, considering their risk tolerance and investment horizon, before making any decisions.
